<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210427051098N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-12-01</date_registration>
      <primary_sponsor>Yazd University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of diet consumption based on high adherence to the global diet quality score on the control of sugar factors, mental health and anthropometric indicators in patients with type 2 diabetes</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of consuming a diet based on high adherence to the Global Diet Quality Score (GDQS) with a standard diet on the control of sugar factors, mental health and anthropometric indicators in patients with type 2 diabetes: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>134</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73088</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization based on gender (male and female) and BMI (above and below 25) as randomization stratified randomization with a block size equal to 8 and 2 times will be repeated. The group assigned to the people will be placed in sealed envelopes in advance and then when the participant visits and after the approval of the eligible The condition of entering the study is that the envelope will be opened and will be placed in the designated group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>diabetes.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:In the diet group based on the GDQS index, people with type 2 diabetes were given GDQS diet training for 3 sessions (the first week before the start of the intervention, the fourth week, and the eighth week of the intervention) and each session lasted 30 minutes. they take. People with type 2 diabetes will be randomly selected and placed in the standard or GDQS group. If there were two participants from the same family with type 2 diabetes, both would be randomly assigned to the standard or GDQS group. The amount of prescribed energy intake for people is calculated according to the Harris-Benedict equation. If the body mass index of people is less than 25, the current weight of people is used to calculate energy; But if the body mass index is more than 25, the adjusted weight of people according to the body mass index of 25 is used to calculate energy. The weight loss phase for overweight and obese people ends immediately after reaching a body mass index of less than 25. People will be taught how to cook different foods according to dietary recommendations. Diet recommendations based on GDQS will be adjusted according to the amount of energy needed by the person, which for a diet containing 1600 calories, 6-8 servings of fruits and vegetables per day, 7-8 servings of nuts and seeds per week, at least 6.5 servings of grains (half 2-3 daily servings of non-fat and low-fat dairy products, maximum 150 grams of meat (with an emphasis on fish and chicken), will be recommended. In training sessions, dietary recommendations based on GDQS will be fully explained to people. These recommendations will be based on the economic status of people's access to food and the status of some other diseases such as digestive diseases. Also, people will be taught how to cook different foods according to dietary recommendations. People's adherence to the diet will be checked once a week through a phone call. People are taught to consume a piece of fruit, a glass of drink with barley bread or crispy bread when mild hypoglycemic symptoms occur (hunger, sweating, increased heart rate, and confusion). Intervention 2: Control group:Prescribing diet in the standard group: the amount of prescribed energy intake for people is calculated according to the Harris-Benedict equation. If the body mass index of people is less than 25, the current weight of people is used to calculate energy; But if the body mass index is more than 25, the adjusted weight of people according to the body mass index of 25 is used to calculate energy. The weight loss phase for overweight and obese people ends immediately after reaching a body mass index of less than 25. People will be taught how to cook different foods according to dietary recommendations. The recommendations of the control diet will be adjusted according to the amount of energy needed by the individual and will contain 55% carbohydrates, 15% protein, 30% fat, and less than 5% energy from simple sugars. These recommendations will be based on the economic status of people's access to food and the status of some other diseases such as digestive diseases. Also, people will be taught how to cook different foods according to dietary recommendations. People's adherence to the diet will be checked once a week through a phone call. The number of training sessions in the standard diet group will be 3 sessions (the first week before the intervention, the fourth week, and the eighth week of the intervention) and healthy food recommendations will be taught to people. People are taught to consume a piece of fruit, a glass of drink with barley bread, or crispy bread when mild hypoglycemic symptoms occur (hunger, sweating, increased heart rate, and confusion). People with type 2 diabetes are randomly placed in this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
primary outcome will be available at the end of study

When:
From January 2024

To whom:
Academic institutions

Conditions:
Academic institutes can send their official request to the email of the scientific director of the project. the data will be sent after confirmation of ethics committee of shahid sadoughi university of medical sciences. It is not possible to perform statistical analysis on the data.

Where to obtain:
Sayyed Saeid Khayyatzadeh Assistant professor of nutrition in Shahid Sadoughi university of medical sciences 
Khayyatzadeh@yahoo.com
 00983538209100

How to obtain:
Academic institutes can send their official request to the email of the scientific director of the project. The data will be sent after confirmation of ethics committee of Shahid Sadoughi university of medical sciences

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sara Bagherpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Alam Square, Yazd City</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8915173160</zip>
        <telephone>+98 35 3149 2228</telephone>
        <email>sarabagherpour1376@gmail.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sayyed Saeid Khayyatzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Alam Square, Yazd City</address>
        <city>Yazd</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8915173160</zip>
        <telephone>+98 35 3149 2228</telephone>
        <email>khayyatzadeh@yahoo.com</email>
        <affiliation>Yazd University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Participants with type 2 diabetes
Fasting blood glucose level ≥ 126 mg/dL
The two-hour plasma glucose level ≥200 mg/dL
Consumption of oral hypoglycemic medications
Body mass index (BMI) ≤ 40 kg/m2
Completion of informed consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Uncontrolled diabetes (HbA1C more than 9 mg/dl)
Suffering from diabetic nephropathy
History of ischemic heart disease
pregnancy
Lactation
History of hospitalization for the treatment of heart disease during the last 6 months
History of cancer treatment in the last 5 years
Suffering from proteinuria
History of steroid treatment during the last 3 months
Suffering from thyroid disease
History of lung disease and compliance with special diet
Suffering from hepatitis
Suffering from gastrointestinal disease
Suffering from pancreatitis
Suffering from inflammatory bowel disease
Bowel resection
Infected with AIDS
Suffering from acute mental disorders
Suffering from Cushing's syndrome
Alcohol consumption
Drug abuse
Taking thiazide diuretics
Taking antidepressants</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Type 2 diabetes mellitus</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:In the diet group based on the GDQS index, people with type 2 diabetes were given GDQS diet training for 3 sessions (the first week before the start of the intervention, the fourth week, and the eighth week of the intervention) and each session lasted 30 minutes. they take. People with type 2 diabetes will be randomly selected and placed in the standard or GDQS group. If there were two participants from the same family with type 2 diabetes, both would be randomly assigned to the standard or GDQS group. The amount of prescribed energy intake for people is calculated according to the Harris-Benedict equation. If the body mass index of people is less than 25, the current weight of people is used to calculate energy; But if the body mass index is more than 25, the adjusted weight of people according to the body mass index of 25 is used to calculate energy. The weight loss phase for overweight and obese people ends immediately after reaching a body mass index of less than 25. People will be taught how to cook different foods according to dietary recommendations. Diet recommendations based on GDQS will be adjusted according to the amount of energy needed by the person, which for a diet containing 1600 calories, 6-8 servings of fruits and vegetables per day, 7-8 servings of nuts and seeds per week, at least 6.5 servings of grains (half 2-3 daily servings of non-fat and low-fat dairy products, maximum 150 grams of meat (with an emphasis on fish and chicken), will be recommended. In training sessions, dietary recommendations based on GDQS will be fully explained to people. These recommendations will be based on the economic status of people's access to food and the status of some other diseases such as digestive diseases. Also, people will be taught how to cook different foods according to dietary recommendations. People's adherence to the diet will be checked once a week through a phone call. People are taught to consume a piece of fruit, a glass of drink with barley bread or crispy bread when mild hypoglycemic symptoms occur (hunger, sweating, increased heart rate, and confusion)</i_keyword>
      <i_keyword>Control group:Prescribing diet in the standard group: the amount of prescribed energy intake for people is calculated according to the Harris-Benedict equation. If the body mass index of people is less than 25, the current weight of people is used to calculate energy; But if the body mass index is more than 25, the adjusted weight of people according to the body mass index of 25 is used to calculate energy. The weight loss phase for overweight and obese people ends immediately after reaching a body mass index of less than 25. People will be taught how to cook different foods according to dietary recommendations. The recommendations of the control diet will be adjusted according to the amount of energy needed by the individual and will contain 55% carbohydrates, 15% protein, 30% fat, and less than 5% energy from simple sugars. These recommendations will be based on the economic status of people's access to food and the status of some other diseases such as digestive diseases. Also, people will be taught how to cook different foods according to dietary recommendations. People's adherence to the diet will be checked once a week through a phone call. The number of training sessions in the standard diet group will be 3 sessions (the first week before the intervention, the fourth week, and the eighth week of the intervention) and healthy food recommendations will be taught to people. People are taught to consume a piece of fruit, a glass of drink with barley bread, or crispy bread when mild hypoglycemic symptoms occur (hunger, sweating, increased heart rate, and confusion). People with type 2 diabetes are randomly placed in this group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>HBA1C. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood test.</prim_outcome>
      <prim_outcome>Fasting Plasma Glucose (FPG). Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood sample.</prim_outcome>
      <prim_outcome>Insulin. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood sample.</prim_outcome>
      <prim_outcome>Insulin resistance index. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Formula.</prim_outcome>
      <prim_outcome>Triacyl glyceride (TG). Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood sample.</prim_outcome>
      <prim_outcome>Total cholesterol. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood sample.</prim_outcome>
      <prim_outcome>High Density Lipoprotein (HDL). Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood sample.</prim_outcome>
      <prim_outcome>Low Density Lipoprotein (LDL). Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Blood sample.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Beck validated questionnaire.</prim_outcome>
      <prim_outcome>Depression. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Beck validated questionnaire.</prim_outcome>
      <prim_outcome>Sleep quality. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: Pittsburgh validated questionnaire.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: Before the intervention, 12 weeks after  the intervention. Method of measurement: SF-36 validated  questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Height. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.</sec_outcome>
      <sec_outcome>Weight. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Weighting scale.</sec_outcome>
      <sec_outcome>Body Mass Index (BMI). Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.</sec_outcome>
      <sec_outcome>Waist circumference. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.</sec_outcome>
      <sec_outcome>Hips circumference. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Tape measure.</sec_outcome>
      <sec_outcome>Fat mass. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.</sec_outcome>
      <sec_outcome>Fat free mass. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Body composition analyzer.</sec_outcome>
      <sec_outcome>Blood pressure. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: Measurement of systolic and diastolic blood pressure (mmHg).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yazd University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-11-25</approval_date>
        <contact_name>Ethics Committee of Shahid Sadoughi University of Medical Sciences</contact_name>
        <contact_address>Shahid Sadoughi University of Medical Sciences and Health Services Campus- Shohadaye Gomnam Blvd- Alem Square- Yazd Yazd Yazd Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
